Total Valuation
ICU Medical has a market cap or net worth of €3.25B. The enterprise value is €4.50B.
Market Cap€3.25B
Enterprise Value€4.50B
Share Statistics
ICU Medical has 24,993,586 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding24,993,586
Owned by Insiders1.92%
Owned by Institutions17.66%
Financial Efficiency
ICU Medical’s return on equity (ROE) is <0.01 and return on invested capital (ROIC) is 0.69%.
Return on Equity (ROE)<0.01
Return on Assets (ROA)<0.01
Return on Invested Capital (ROIC)0.69%
Return on Capital Employed (ROCE)0.03
Revenue Per Employee148.67K
Profits Per Employee48.80
Employee Count15,000
Asset Turnover0.55
Inventory Turnover2.29
Valuation Ratios
The current PE Ratio of ICU Medical is 79.1. ICU Medical’s PEG ratio is -47.74.
PE Ratio79.1
PS Ratio1.58
PB Ratio1.66
Price to Fair Value1.66
Price to FCF38.29
Price to Operating Cash Flow21.88
PEG Ratio-47.74
Income Statement
In the last 12 months, ICU Medical had revenue of 2.23B and earned 732.00K in profits. Earnings per share was 0.03.
Revenue2.23B
Gross Profit819.65M
Operating Income106.95M
Pretax Income3.17M
Net Income732.00K
EBITDA326.54M
Earnings Per Share (EPS)0.03
Cash Flow
In the last 12 months, operating cash flow was 167.43M and capital expenditures -87.03M, giving a free cash flow of 80.40M billion.
Operating Cash Flow167.43M
Free Cash Flow80.40M
Free Cash Flow per Share3.22
Dividends & Yields
ICU Medical pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.48
52-Week Price Change15.18%
50-Day Moving Average112.43
200-Day Moving Average115.74
Relative Strength Index (RSI)68.36
Average Volume (3m)3.00
Important Dates
ICU Medical upcoming earnings date is Aug 10, 2026, After Close (Confirmed).
Last Earnings DateMay 7, 2026
Next Earnings DateAug 10, 2026
Ex-Dividend Date―
Financial Position
ICU Medical as a current ratio of 2.36, with Debt / Equity ratio of 63.51%
Current Ratio2.36
Quick Ratio1.13
Debt to Market Cap0.38
Net Debt to EBITDA3.32
Interest Coverage Ratio1.01
Taxes
In the past 12 months, ICU Medical has paid 2.44M in taxes.
Income Tax2.44M
Effective Tax Rate0.77
Enterprise Valuation
ICU Medical EV to EBITDA ratio is 14.09, with an EV/FCF ratio of 50.10.
EV to Sales2.06
EV to EBITDA14.09
EV to Free Cash Flow50.10
EV to Operating Cash Flow25.58
Balance Sheet
ICU Medical has €288.33M in cash and marketable securities with €1.34B in debt, giving a net cash position of -€1.05B billion.
Cash & Marketable Securities€288.33M
Total Debt€1.34B
Net Cash-€1.05B
Net Cash Per Share-€42.13
Tangible Book Value Per Share-€0.39
Margins
Gross margin is 36.36%, with operating margin of 4.80%, and net profit margin of 0.03%.
Gross Margin36.36%
Operating Margin4.80%
Pretax Margin0.14%
Net Profit Margin0.03%
EBITDA Margin14.64%
EBIT Margin4.87%
Analyst Forecast
The average price target for ICU Medical is €145.35, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target€145.35
Price Target Upside18.17% Upside
Analyst ConsensusStrong Buy
Analyst Count4
Revenue Growth Forecast-17.35%
EPS Growth Forecast―